| Annual · values | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -5.13 M USD | -4.63 M USD | -3.53 M USD | -2.99 M USD | -2.81 M USD | -297055 USD | -894470 USD | -1.11 M USD | -92858 USD | -147923 USD | — |
| Depreciation & Amortization | 193797 USD | 285054 USD | 287722 USD | 330143 USD | 308741 USD | 160108 USD | 72188 USD | 37011 USD | 0 USD | — | — |
| Stock-Based Compensation | 2.63 M USD | 1.41 M USD | 499856 USD | 732130 USD | 365000 USD | 2.00 M USD | 252700 USD | 1.76 M USD | — | 7770 USD | — |
| Capital Expenditures | 5324 USD | 92043 USD | 51761 USD | 79304 USD | 81595 USD | — | — | 4163 USD | — | — | — |
| Cash Flow from Investing | -5324 USD | -92043 USD | -51761 USD | -79304 USD | -81595 USD | 66994 USD | — | -404163 USD | — | — | — |
| Cash Flow from Financing | 5.40 M USD | 8.54 M USD | 2.09 M USD | 160074 USD | 7.63 M USD | 371873 USD | 430250 USD | 1.98 M USD | 65762 USD | 174900 USD | — |
| Dividends Paid | — | — | — | — | — | — | — | — | — | — | — |
| Stock Buybacks | — | — | — | — | — | — | — | — | — | — | — |
| Free Cash Flow | -5.14 M USD | -4.72 M USD | -3.58 M USD | -3.07 M USD | -2.89 M USD | — | — | -1.11 M USD | — | — | — |
Nutriband Inc. is a pharmaceutical and healthcare company specializing in the development and commercialization of transdermal products and technologies. The primary focus of Nutriband is to improve the safety and efficacy of drug delivery systems. By leveraging transdermal adhesive materials, Nutriband Inc. offers an innovative approach to drug administration that bypasses the gastrointestinal tract and liver, enabling a more direct and controlled delivery to the bloodstream. This approach can reduce side effects and improve patient compliance. Nutriband's technologies have broader applications not only in delivering medications effectively but also in enhancing safety in medical treatments, which is critical across pharmaceutical and biotechnology industries. With its commitment to therapeutic advancements, Nutriband Inc. plays an essential role in the ongoing transformation of drug delivery systems, potentially impacting a variety of treatment areas and improving patients' experiences across different healthcare settings.